Back to search

Aristotle University Of Thessaloniki (AUTH)

Σύγκριση των δράσεων της ατενολόλης και των νεώτερων β-αποκλειστών στις ελαστικές ιδιότητες της αορτής υπερτασικών ασθενών

Abstract

dc:description

The aim of the present study was to compare the effects of an angiotensin-converting enzyme inhibitor (quinapril), the first renin inhibitor (aliskiren), a conventional cardioselective beta-blocker (atenolol) and a vasodilating beta-blocker (nebivolol) on markers of aortic stiffness in treatment-naïve patients with uncomplicated, stage I-II, essential hypertension.72 treatment-naïve, adult patients (68.1% males, age 47.6 ± 10.6 years) with mean sitting systolic blood pressure (BP) 140-180 mmHg and/or mean sitting diastolic BP 90-110 mmHg (confirmed on at least 3 occasions separated by a month) and 20 normotensive (systolic BP < 140 mmHg and diastolic BP < 90 mmHg) adults (65.0% males, age 40.0 ± 8.9 years) were recruited from the Second Propedeutic Department of Internal Medicine of Aristotle University, at the Hippokration General Hospital in Thessaloniki. Patients were randomized to quinapril 20 mg qd (n = 20), aliskiren 150 mg qd (n = 18), atenolol 50 mg qd (n = 17) or nebivolol 5 mg qd (n = 17). Peripheral BP and markers of aortic stiffness were measured at baseline and after 2 and 12 weeks of treatment and only at baseline in normotensive controls. The drug doses could be adjusted after the 2nd visit, in order to achieve the target peripheral BP of < 140/90 mmHg. Central BP indices and markers of aortic stiffness were assessed using applanation tonometry with the SphygmoCor device (Atcor Medical, Sydney, Australia). The study protocol was approved by Aristotle University Bioethics Committee. All patients provided written informed consent. Data analysis was performed with the statistical package for the social sciences (SPSS, version 17.0, SPSS Inc., Chicago, IL). The 4 groups of hypertensive patients did not differ in baseline characteristics, except for the marginally higher augmentation index (AIx) in patients assigned to aliskiren than in those assigned to atenolol (p = 0.015). Controls had lower central systolic BP, central diastolic BP and pulse wave velocity (PWV) than all groups of hypertensive patients. Central pulse pressure (PP) was lower in controls than in patients assigned to aliskiren (p = 0.004) but did not differ between controls and other groups of hypertensive patients. The AIx was lower in controls than in patients assigned to quinapril, aliskiren or nebivolol (p = 0.006, p < 0.001 and p < 0.001, respectively) but did not differ between controls and patients assigned to atenolol.Central systolic BP and central diastolic BP decreased in all groups. In contrast, central PP and AIx decreased in patients treated with quinapril, aliskiren or nebivolol but did not change significantly in patients treated with atenolol. PWV decreased in all groups during the study and between baseline and the second visit. However, PWV between the second and the last visit did not change in patients treated with atenolol or nebivolol, whereas it decreased significantly in patients treated with quinapril or aliskiren.The decrease in central and peripheral systolic BP, diastolic BP, PP and PWV did not differ between the 4 groups. In contrast, AIx increased in patients treated with atenolol, but decreased similarly in those treated with quinapril, aliskiren or nebivolol (p = 0.001, p = 0.001 and p = 0.027, respectively).The present study suggests that atenolol exerts less beneficial effects on markers of aortic stiffness, namely AIx, against quinapril and aliskiren and the vasodilating beta-blocker nebivolol, despite similar reductions in peripheral BP. In addition, nebivolol, aliskiren and quinapril are equally effective in improving markers of aortic stiffness. Nebivolol, however, seems to exert a more short-term effect than aliskiren and quinapril, at least in terms of PWV.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koumaras, Charalampos
  • Κουμαράς, Χαράλαμπος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35154

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koumaras, Charalampos; Κουμαράς, Χαράλαμπος. Σύγκριση των δράσεων της ατενολόλης και των νεώτερων β-αποκλειστών στις ελαστικές ιδιότητες της αορτής υπερτασικών ασθενών. Aristotle University Of Thessaloniki (AUTH), 2014. http://hdl.handle.net/10442/hedi/35154